placeholder image

P. C. Bellman All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study. 

    • Contact

    full name

  • P. C. Bellman

    • Quick Info

    Publications

    Collaboration